Median Technologies recently announced a research collaboration agreement with Xingtai People's Hospital, Xingtai City, China. Within the frame of the agreement, Median's MediScan image analysis technology will be used to conduct lung cancer screening programs organized under the aegis of Xingtai People's Hospital in Xingtai City. These programs are critically important to improving the health of the people of Xingtai City since the incidence of and mortality associated with lung cancer have increased dramatically in China and become a nationwide public health issue, giving rise to an increased burden on patients, healthcare professionals and society.